7-30595148-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002047.4(GARS1):c.222+5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0984 in 1,535,676 control chromosomes in the GnomAD database, including 8,528 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002047.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARS1 | NM_002047.4 | c.222+5C>T | splice_region_variant, intron_variant | ENST00000389266.8 | NP_002038.2 | |||
GARS1 | NM_001316772.1 | c.60+5C>T | splice_region_variant, intron_variant | NP_001303701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.222+5C>T | splice_region_variant, intron_variant | 1 | NM_002047.4 | ENSP00000373918.3 | ||||
GARS1 | ENST00000675651.1 | c.222+5C>T | splice_region_variant, intron_variant | ENSP00000502513.1 | ||||||
GARS1 | ENST00000675810.1 | c.222+5C>T | splice_region_variant, intron_variant | ENSP00000502743.1 | ||||||
GARS1 | ENST00000675693.1 | c.54+5C>T | splice_region_variant, intron_variant | ENSP00000502174.1 | ||||||
GARS1 | ENST00000675051.1 | c.22-3648C>T | intron_variant | ENSP00000502296.1 | ||||||
GARS1 | ENST00000674815.1 | c.-148+196C>T | intron_variant | ENSP00000502799.1 | ||||||
GARS1 | ENST00000674851.1 | c.-148+5C>T | splice_region_variant, intron_variant | ENSP00000502451.1 | ||||||
GARS1 | ENST00000444666.6 | n.222+5C>T | splice_region_variant, intron_variant | 3 | ENSP00000415447.2 | |||||
GARS1 | ENST00000674616.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000502408.1 | ||||||
GARS1 | ENST00000674643.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000501636.1 | ||||||
GARS1 | ENST00000674737.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000502464.1 | ||||||
GARS1 | ENST00000674807.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000502814.1 | ||||||
GARS1 | ENST00000675529.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000501655.1 | ||||||
GARS1 | ENST00000675859.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000502033.1 | ||||||
GARS1 | ENST00000676088.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000501884.1 | ||||||
GARS1 | ENST00000676140.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000502571.1 | ||||||
GARS1 | ENST00000676164.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000501986.1 | ||||||
GARS1 | ENST00000676210.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000502373.1 | ||||||
GARS1 | ENST00000676259.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000501980.1 | ||||||
GARS1 | ENST00000676403.1 | n.222+5C>T | splice_region_variant, intron_variant | ENSP00000502681.1 |
Frequencies
GnomAD3 genomes AF: 0.102 AC: 15547AN: 152122Hom.: 880 Cov.: 32
GnomAD3 exomes AF: 0.113 AC: 15584AN: 138328Hom.: 1062 AF XY: 0.117 AC XY: 8729AN XY: 74722
GnomAD4 exome AF: 0.0980 AC: 135578AN: 1383436Hom.: 7646 Cov.: 35 AF XY: 0.100 AC XY: 68563AN XY: 682804
GnomAD4 genome AF: 0.102 AC: 15558AN: 152240Hom.: 882 Cov.: 32 AF XY: 0.103 AC XY: 7671AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:5
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 28, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 09, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Molecular Genetics Laboratory, London Health Sciences Centre | - | - - |
Distal spinal muscular atrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Charcot-Marie-Tooth disease type 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 15, 2016 | - - |
Charcot-Marie-Tooth disease type 2D Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Neuronopathy, distal hereditary motor, type 5A Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at